Jacqueline Soto-Sánchez

Prof. Dr. Jacqueline Soto-Sánchez

orcid
Section of Postgraduate Studies and Research, Escuela Nacion...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2018 in Genes
Verified
Journal Article
Open access
PDF file
JOJuan David Ospina-Villa
Juan David Ospina-Villa
César López-CamarilloCésar López-Camarillo
César López-Camarillo
CCCarlos A. Castañón-Sánchez
Carlos A. Castañón-Sánchez
Jacqueline Soto-SánchezJacqueline Soto-Sánchez
Jacqueline Soto-Sánchez
EREsther Ramírez-Moreno
Esther Ramírez-Moreno
LMLaurence A Marchat
Laurence A Marchat
Aptamers are single-stranded DNA or RNA sequences with a unique three-dimensional structure that allows them to recognize a particular target with high affinity. Although their specific recognition activity could make them similar to monoclonal antibodies, their ability to bind to a large range of non-immunogenic targets greatly expands their potential as tools for diagnosis, therapeutic agents, detection of food risks, biosensors, detection of toxins, drug carriers, and nanoparticle markers, among others. One aptamer named Pegaptanib is currently used for treating macular degeneration associated with age, and many other aptamers are in different clinical stages of development of evaluation for various human diseases. In the area of parasitology, research on aptamers has been growing rapidly in the past few years. Here we describe the development of aptamers raised against the main protozoan parasites that affect hundreds of millions of people in underdeveloped and developing countries, remaining a major health concern worldwide, i.e. Trypanosoma spp., Plasmodium spp., Leishmania spp., Entamoeba histolytica, and Cryptosporidium parvuum. The latest progress made in this area confirmed that DNA and RNA aptamers represent attractive alternative molecules in the search for new tools to detect and treat these parasitic infections that affect human health worldwide.

1 November 2015 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
VBVerónica Bolaños
Verónica Bolaños
ADAlfredo Díaz-Martínez
Alfredo Díaz-Martínez
Jacqueline Soto-SánchezJacqueline Soto-Sánchez
Jacqueline Soto-Sánchez
LMLaurence A Marchat
Laurence A Marchat
VSVirginia Sanchez-Monroy
Virginia Sanchez-Monroy
EREsther Ramírez-Moreno
Esther Ramírez-Moreno

1 December 2014 in Journal of Proteomics
Verified
Journal Article
Closed access
VBVerónica Bolaños
Verónica Bolaños
ADAlfredo Díaz-Martínez
Alfredo Díaz-Martínez
Jacqueline Soto-SánchezJacqueline Soto-Sánchez
Jacqueline Soto-Sánchez
MRMario Alberto Rodriguez
Mario Alberto Rodriguez
César López-CamarilloCésar López-Camarillo
César López-Camarillo
EREsther Ramírez-Moreno
Esther Ramírez-Moreno

1 November 2022 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Jacqueline Soto-SánchezJacqueline Soto-Sánchez
Jacqueline Soto-Sánchez
Background: Leishmaniasis and trypanosomiasis are diseases that affect public health worldwide due to their high incidence, morbidity, and mortality. Available treatments are costly, prolonged, and toxic, not to mention the problem of parasite resistance. The development of alternative treatments is justified and polyphenols show promising activity. Objective: The main aim of this mini-review was to analyze the most promising phenolic compounds with reported antileishmanial and antitrypanosomal activity as well as their mechanisms of action. Results: We found that the mode of action of these natural compounds, mainly lignans, neolignans, and flavonoids depends on the organism they act on and includes macrophage activation, induction of morphological changes such as chromatin condensation, DNA fragmentation, accumulation of acidocalcisomes, and glycosomes, Golgi damage and mitochondrial dysfunction as well as negative regulation of mitochondrial enzymes and other essential enzymes for parasite survival such as arginase. This gives a wide scope for future research toward the rational development of anti-kinetoplastid drugs. Conclusion: Although the specific molecular targets, bioavailability, route of administration, and dosages of some of these natural compounds need to be determined, polyphenols and their combinations represent a very promising and safe strategy to be considered for use against Leishmania spp and Trypanosoma spp. In addition, these compounds may provide a scaffold for developing new, more potent, and more selective antiprotozoal agents.

28 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMarisol Pezet-Valdez
Marisol Pezet-Valdez
JFJorge Fernández-Retana
Jorge Fernández-Retana
JOJuan David Ospina-Villa
Juan David Ospina-Villa
MRMaría Esther Ramírez-Moreno
María Esther Ramírez-Moreno
EOEsther Orozco
Esther Orozco
LMLaurence A Marchat
Laurence A Marchat
In eukaryotes, polyadenylation of pre-mRNA 3´ end is essential for mRNA export, stability and translation. Taking advantage of the knowledge of genomic sequences of Entamoeba histolytica, the protozoan responsible for human amoebiasis, we previously reported the putative polyadenylation machinery of this parasite. Here, we focused on the predicted protein that has the molecular features of the 25 kDa subunit of the Cleavage Factor Im (CFIm25) from other organisms, including the Nudix (nucleoside diphosphate linked to another moiety X) domain, as well as the RNA binding domain and the PAP/PAB interacting region. The recombinant EhCFIm25 protein (rEhCFIm25) was expressed in bacteria and used to generate specific antibodies in rabbit. Subcellular localization assays showed the presence of the endogenous protein in nuclear and cytoplasmic fractions. In RNA electrophoretic mobility shift assays, rEhCFIm25 was able to form specific RNA-protein complexes with the EhPgp5 mRNA 3´ UTR used as probe. In addition, Pull-Down and LC/ESI-MS/MS tandem mass spectrometry assays evidenced that the putative EhCFIm25 was able to interact with the poly(A) polymerase (EhPAP) that is responsible for the synthesis of the poly(A) tail in other eukaryotic cells. By Far-Western experiments, we confirmed the interaction between the putative EhCFIm25 and EhPAP in E. histolytica. Taken altogether, our results showed that the putative EhCFIm25 is a conserved RNA binding protein that interacts with the poly(A) polymerase, another member of the pre-mRNA 3´ end processing machinery in this protozoan parasite.

6 January 2020 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
Jacqueline Soto-SánchezJacqueline Soto-Sánchez
Jacqueline Soto-Sánchez
LCLuis A. Caro-Gómez
Luis A. Caro-Gómez
APALMA PAZ
ALMA PAZ
LMLaurence A Marchat
Laurence A Marchat
Gildardo RiveraGildardo Rivera
Gildardo Rivera
EREsther Ramírez-Moreno
Esther Ramírez-Moreno